The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 09, 2019

Filed:

Jun. 24, 2016
Applicants:

Memorial Sloan Kettering Cancer Center, New York, NY (US);

Cornell University, Ithaca, NY (US);

Inventors:

Richard John O'Reilly, Roxbury, CT (US);

Susan Elizabeth Prockop, New York, NY (US);

Ekaterina Doubrovina, Bronx, NY (US);

Guenther Koehne, New York, NY (US);

Aisha Nasreen Hasan, New York, NY (US);

Szilard Kiss, New York, NY (US);

Assignees:

Memorial Sloan Kettering Cancer Center, New York, NY (US);

Cornell University, Ithaca, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/70 (2006.01); A61K 35/17 (2015.01); A61K 39/00 (2006.01); A61K 39/12 (2006.01); A61K 45/06 (2006.01); A61K 39/245 (2006.01);
U.S. Cl.
CPC ...
A61K 39/245 (2013.01); A61K 35/17 (2013.01); A61K 39/12 (2013.01); A61K 45/06 (2013.01); C12Q 1/705 (2013.01); A61K 2039/5158 (2013.01); C12N 2710/16134 (2013.01);
Abstract

Methods of treating CMV (cytomegalovirus) retinitis in a human patient in need thereof, comprising administering to the human patient a population of allogeneic T cells comprising CMV-specific T cells, wherein the human patient is infected with human immunodeficiency virus (HIV) or has been the recipient of a solid organ transplant.


Find Patent Forward Citations

Loading…